Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Cancers|July 29, 2025
Toxicity Profiles of Antibody-Drug Conjugates: Synthesis and Graphical Insights to Optimize Patient-Centered Treatment Strategies for HER2-Negative Metastatic Breast CancerBérénice Collineau, Anthony Gonçalves, Marie Domon, et al.Bulletin Du Cancer|October 24, 2025
[Pathophysiological rationale and management of anxio-depressive syndrome among cancer patients]Jean-Baptiste Demigné, Vincent Sylvestre, Damien Bruyat, et al.Journal of Palliative Care|July 31, 2026
Continuous Intravenous Lidocaine for Refractory Cancer Pain in Palliative Care: A Multicenter Feasibility StudyDamien Bruyat, Matthieu Frasca, Karine Baumstarck, et al.Clinical Genitourinary Cancer|December 25, 2024
A French Multicenter Real-Life Study on the Biological and Clinical Parameters Associated With Response to Immune Checkpoint Inhibitors (ICIs) in Second-Line Treatment of Advanced Urothelial Carcinoma: Impact of Antibiotics Administration at the Time of ICIs InitiationPierre Grassi, Werner Hilgers, Romain Boissier, et al.JCO Oncology Practice|December 15, 2025
Factors Associated With Toxicity of FOLFIRINOX in Elderly Patients With Pancreatic Ductal AdenocarcinomaBerenice Collineau, Cecile Bannier-Braticevic, Julia Gilhodes, et al.Cell Reports|October 9, 2025
BTN2A1 acquisition through trogocytosis enhances Vγ9Vδ2 T cell cytotoxicity against autologous and cancer cellsEmilien Billon, Caroline Imbert, Damien Bruyat, et al.Journal for Immunotherapy of Cancer|August 3, 2023
Dysthyroidism during immune checkpoint inhibitors is associated with improved overall survival in adult cancers: data mining of 1385 electronic patient recordsMathilde Beaufils, Vincent Amodru, Manuel Tejeda, et al.Pageof 1